Wolf Haldenstein Adler Freeman & Herz LLP has opened an investigation into Curanex Pharmaceuticals and certain officers for possible securities fraud following extreme stock price volatility after its IPO in August 2025. The stock price surged from $4.00 at IPO to a peak of $9.16 before crashing to $1.51 amidst heavy trading volumes, leading to a trading halt. Shareholders who suffered losses may have claims, and the law firm is inviting affected investors to contact them for potential legal action. This investigation highlights risks in volatile biotech stocks and may lead to shareholder litigation if wrongdoing is found.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Frasers Group PLC has withheld financial guidance for the upcoming year due to uncertainty around its takeover bids for Hugo Boss and Accent Group. The retailer's full-year adjusted profit before tax fell 4% to £538 million, impacted by asset impairm...
Ethereum rose 3.17% to $1,923.53, outperforming Bitcoin's modest 0.18% gain to $64,588.87, signaling an early rotation toward large-cap altcoins. Despite this, overall market activity slowed, with declines in DeFi, stablecoin, and derivatives trading...
Gabriel Holding A/S has agreed to sell its European FurnMaster furniture manufacturing operations, including subsidiaries in Poland and Lithuania, to Leggett & Platt for an initial price of approximately EUR 9 million, with a possible additional paym...
A Gaza resident raised over £55,000 on GoFundMe to support his family but faced issues as the platform cannot pay directly to Gaza, forcing funds through intermediaries who failed to deliver the full amount. This highlights a broader problem in human...
